Virtus Investment Advisers, LLC — 13F Holdings

2026 Q3  ·  507 Positions

2026 Q3 Portfolio Activity

In 2026 Q3, Virtus Investment Advisers, LLC maintained a portfolio of 507 distinct positions. The most significant new addition was OKTA INC, now representing 0.65% of the total fund value. They heavily accumulated shares in IOVANCE BIOTHERAPEUTICS INC, increasing the position by 44.9%. Conversely, Virtus Investment Advisers, LLC completely exited their position in ILLUMINA INC.
Position History hover any row below to update
Loading…
PCA Score Concentration Risk
Risk ENB
Total Positions
507
Quarter
2026 Q3
Top Holding
MRNA (1.4%)
Top 10 Concentration
9.5%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
Showing 1-50 of 507

Virtus Investment Advisers, LLC Full Holdings List — 2026 Q3

Stock History Sector / Type Port % Prev % Rank / Prev Conviction
Freshness
Change % Change Influence Shares Mkt Value Avg Cost Price Held 1st Owned Source Source Date Date Reported
MRNA
MODERNA INC
Healthcare 1.44% 0.38% #1 104
Prev: #105
5.1
—
10,470 44.9%
P
S
33,770 $6,503,089
$75.48 +206.5%
$192.57 +20.1%
2025 Q1 13F Filing 2026-09-30 2026-11-12
IOVA
IOVANCE BIOTHER...
Healthcare 1.35% 0.28% #2 180
Prev: #182
4.5
—
128,091 44.9%
P
S
413,111 $6,122,305 2025 Q1 13F Filing 2026-09-30 2026-11-12
REGN
REGENERON PHARM...
Healthcare 0.92% 0.63% #3 12
Prev: #15
3.9
—
1,170 27.1%
P
S
5,490 $4,162,902 2007 Q1 13F Filing 2026-09-30 2026-11-12
GILD
GILEAD SCIENCES...
Healthcare 0.91% 0.69% #4 7
Prev: #11
2.9
—
4,219 18.1%
P
S
27,587 $4,111,842 2003 Q2 13F Filing 2026-09-30 2026-11-12
AMGN
AMGEN INC
Healthcare 0.89% 0.72% #5 2
Prev: #7
2.9
—
1,014 11.8%
P
S
9,586 $4,040,595 2003 Q2 13F Filing 2026-09-30 2026-11-12
VRTX
VERTEX PHARMACE...
Healthcare 0.89% 0.30% #6 147
Prev: #153
3.4
—
5,054 193.3%
P
S
7,668 $4,008,907 2016 Q3 13F Filing 2026-09-30 2026-11-12
OMER
OMEROS CORP
Healthcare 0.81% 0.29% #7 158
Prev: #165
2.8
—
59,830 44.9%
P
S
192,959 $3,673,939 2025 Q1 13F Filing 2026-09-30 2026-11-12
INCY
INCYTE CORP
Healthcare 0.81% 0.78% #8 4
Prev: #4
0.8
—
633 2.1%
P
S
30,177 $3,661,979 2017 Q2 13F Filing 2026-09-30 2026-11-12
BMRN
BIOMARIN PHARMA...
Healthcare 0.81% 0.28% #9 171
Prev: #180
3.3
—
39,999 192.5%
P
S
60,783 $3,646,980 2003 Q2 13F Filing 2026-09-30 2026-11-12
VSTM
VERASTEM INC
Healthcare 0.73% 0.25% #10 177
Prev: #187
2.8
—
127,467 44.9%
P
S
411,097 $3,309,331 2025 Q4 13F Filing 2026-09-30 2026-11-12
PGEN
PRECIGEN INC
Healthcare 0.72% 0.35% #11 109
Prev: #120
2.8
—
117,441 44.9%
P
S
378,763 $3,242,211 2025 Q4 13F Filing 2026-09-30 2026-11-12
OKTA
OKTA INC
Technology 0.65% — #12
Prev: #—
3.8
—
13,971 —
NEW
13,971 $2,921,476 2017 Q4 13F Filing 2026-09-30 2026-11-12
MRVL
MARVELL TECHNOL...
Technology 0.64% 0.79% #13 10
Prev: #3
0.8
—
-487 -4.3%
P
S
10,907 $2,881,738 2002 Q3 13F Filing 2026-09-30 2026-11-12
HALO
HALOZYME THERAP...
Healthcare 0.59% 0.31% #14 135
Prev: #149
2.7
—
7,520 44.9%
P
S
24,252 $2,677,421 2022 Q3 13F Filing 2026-09-30 2026-11-12
HPE
HEWLETT PACKARD...
Technology 0.59% — #15
Prev: #—
3.7
—
41,739 —
NEW
41,739 $2,666,705 2016 Q3 13F Filing 2026-09-30 2026-11-12
ZLAB
ZAI LAB LTD
Healthcare 0.57% 0.30% #16 140
Prev: #156
2.7
—
30,617 44.9%
P
S
98,741 $2,600,838 2025 Q1 13F Filing 2026-09-30 2026-11-12
AMD
ADVANCED MICRO ...
Technology 0.57% 0.73% #17 11
Prev: #6
0.2
—
-1,199 -22.3%
P
S
4,186 $2,560,827 2003 Q1 13F Filing 2026-09-30 2026-11-12
RIGL
RIGEL PHARMACEU...
Healthcare 0.55% 0.32% #18 119
Prev: #137
2.7
—
15,909 44.9%
P
S
51,309 $2,470,528 2025 Q4 13F Filing 2026-09-30 2026-11-12
MU
MICRON TECHNOLO...
Technology 0.55% 0.92% #19 18
Prev: #1
0.2
—
-1,119 -32.5%
P
S
2,319 $2,469,990 2002 Q2 13F Filing 2026-09-30 2026-11-12
KNSA
KINIKSA PHARMAC...
Healthcare 0.54% 0.33% #20 110
Prev: #130
2.7
—
10,072 44.9%
P
S
32,483 $2,423,557 2025 Q1 13F Filing 2026-09-30 2026-11-12
NEM
NEWMONT CORP
Basic Materials 0.53% 0.34% #21 106
Prev: #127
2.7
—
5,265 33.9%
P
S
20,793 $2,398,265 2003 Q4 13F Filing 2026-09-30 2026-11-12
XERS
XERIS BIOPHARMA...
Healthcare 0.52% 0.32% #22 121
Prev: #143
2.7
—
76,969 44.9%
P
S
248,233 $2,373,107 2025 Q1 13F Filing 2026-09-30 2026-11-12
PANW
PALO ALTO NETWO...
Technology 0.52% — #23
Prev: #—
3.7
—
5,965 —
NEW
5,965 $2,369,954 2025 Q2 13F Filing 2026-09-30 2026-11-12
STX
SEAGATE TECHNOL...
Technology 0.52% — #24
Prev: #—
3.7
—
2,547 —
NEW
2,547 $2,349,200 2007 Q4 13F Filing 2026-09-30 2026-11-12
A
AGILENT TECHNOL...
Healthcare 0.52% 0.48% #25 10
Prev: #35
0.7
—
-2,049 -13.1%
P
S
13,540 $2,333,077 2003 Q4 13F Filing 2026-09-30 2026-11-12
ONC
BEONE MEDICINES...
Healthcare 0.52% 0.29% #26 144
Prev: #170
2.7
—
1,976 44.9%
P
S
6,373 $2,332,136 2025 Q1 13F Filing 2026-09-30 2026-11-12
GLW
CORNING INC
Technology 0.51% 0.64% #27 13
Prev: #14
2.7
—
4,373 40.8%
P
S
15,101 $2,321,930 2003 Q3 13F Filing 2026-09-30 2026-11-12
LRCX
LAM RESEARCH CO...
Technology 0.51% 0.70% #28 19
Prev: #9
0.7
—
115 1.7%
P
S
7,059 $2,318,952 2002 Q2 13F Filing 2026-09-30 2026-11-12
NTAP
NETAPP INC
Technology 0.51% 0.60% #29 12
Prev: #17
0.2
—
-5,717 -34.4%
P
S
10,903 $2,290,502 2008 Q1 13F Filing 2026-09-30 2026-11-12
ANET
ARISTA NETWORKS...
Technology 0.50% 0.41% #30 51
Prev: #81
2.2
—
765 7.3%
P
S
11,213 $2,282,855 2024 Q4 13F Filing 2026-09-30 2026-11-12
KEYS
KEYSIGHT TECHNO...
Technology 0.50% 0.43% #31 37
Prev: #68
2.2
—
945 17.9%
P
S
6,236 $2,270,153 2022 Q3 13F Filing 2026-09-30 2026-11-12
FTNT
FORTINET INC
Technology 0.50% — #32
Prev: #—
3.7
—
12,688 —
NEW
12,688 $2,268,107 2025 Q1 13F Filing 2026-09-30 2026-11-12
IBRX
IMMUNITYBIO INC
Healthcare 0.49% 0.33% #33 96
Prev: #129
2.7
—
73,608 44.9%
P
S
237,394 $2,240,999 2025 Q1 13F Filing 2026-09-30 2026-11-12
APH
AMPHENOL CORP
Technology 0.49% 0.50% #34 3
Prev: #31
3.2
—
14,331 118.2%
P
S
26,458 $2,230,409 2003 Q1 13F Filing 2026-09-30 2026-11-12
NVDA
NVIDIA CORPORAT...
Technology 0.49% 0.39% #35 60
Prev: #95
2.2
—
1,338 16.1%
P
S
9,659 $2,205,922 2007 Q2 13F Filing 2026-09-30 2026-11-12
WAT
WATERS CORP
Healthcare 0.48% — #36
Prev: #—
3.7
—
4,957 —
NEW
4,957 $2,178,056 2003 Q2 13F Filing 2026-09-30 2026-11-12
PTGX
PROTAGONIST THE...
Healthcare 0.48% 0.30% #37 115
Prev: #152
2.7
—
4,761 44.9%
P
S
15,354 $2,163,225 2025 Q1 13F Filing 2026-09-30 2026-11-12
GRMN
GARMIN LTD
Technology 0.48% 0.39% #38 58
Prev: #96
2.2
—
499 7.1%
P
S
7,503 $2,152,161 2002 Q2 13F Filing 2026-09-30 2026-11-12
QCOM
QUALCOMM INC
Technology 0.47% — #39
Prev: #—
3.7
—
11,684 —
NEW
11,684 $2,150,323 2002 Q2 13F Filing 2026-09-30 2026-11-12
TARS
TARSUS PHARMACE...
Healthcare 0.47% 0.28% #40 144
Prev: #184
2.7
—
8,436 44.9%
P
S
27,207 $2,138,742 2025 Q1 13F Filing 2026-09-30 2026-11-12
ETN
EATON CORP PLC
Industrials 0.47% 0.43% #41 28
Prev: #69
2.2
—
602 13.9%
P
S
4,926 $2,116,751 2002 Q4 13F Filing 2026-09-30 2026-11-12
WST
WEST PHARMACEUT...
Healthcare 0.46% 0.50% #42 12
Prev: #30
0.7
—
-319 -5.3%
P
S
5,646 $2,093,311 2003 Q4 13F Filing 2026-09-30 2026-11-12
COP
CONOCOPHILLIPS
Energy 0.46% — #43
Prev: #—
3.7
—
16,678 —
NEW
16,678 $2,087,252 2002 Q3 13F Filing 2026-09-30 2026-11-12
PWR
QUANTA SVCS INC
Industrials 0.46% 0.47% #44 7
Prev: #37
2.2
—
407 14.4%
P
S
3,234 $2,077,877 2003 Q4 13F Filing 2026-09-30 2026-11-12
DDOG
DATADOG INC
Technology 0.46% 0.82% #45 43
Prev: #2
0.2
—
-6,001 -44.2%
P
S
7,586 $2,077,426 2025 Q3 13F Filing 2026-09-30 2026-11-12
FOXA
FOX CORP
Communication Services 0.46% 0.34% #46 75
Prev: #121
2.2
—
4,745 16.8%
P
S
32,969 $2,065,508 2016 Q3 13F Filing 2026-09-30 2026-11-12
ADI
ANALOG DEVICES ...
Technology 0.46% — #47
Prev: #—
3.7
—
5,201 —
NEW
5,201 $2,063,289 2002 Q2 13F Filing 2026-09-30 2026-11-12
LGND
LIGAND PHARMACE...
Healthcare 0.45% 0.34% #48 80
Prev: #128
2.7
—
2,044 44.9%
P
S
6,595 $2,060,080 2025 Q1 13F Filing 2026-09-30 2026-11-12
ADMA
ADMA BIOLOGICS ...
Healthcare 0.45% 0.28% #49 134
Prev: #183
2.7
—
63,656 44.9%
P
S
205,298 $2,059,139 2023 Q2 13F Filing 2026-09-30 2026-11-12
AMZN
AMAZON COM INC
Consumer Cyclical 0.45% 0.38% #50 50
Prev: #100
2.2
—
1,340 19.4%
P
S
8,243 $2,053,743 2004 Q3 13F Filing 2026-09-30 2026-11-12
Showing 1-50 of 507 holdings

Unlock Full Virtus Investment Advisers, LLC Analysis

PRO subscribers get access to all historical quarters, Excel/CSV exports, Portfolio Concentration Analytics (PCA), and Risk-Based ENB.

Full Historical Quarters
Excel & CSV Export
PCA & Risk-Based ENB
Auto Cost Basis
Position Change Alerts
Price-Held Analytics
Full history →